Reduced innate immune response, apoptosis, and virus release in cells cured of respiratory syncytial virus persistent infection  by Herranz, Cristina et al.
Virology 410 (2011) 56–63
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roReduced innate immune response, apoptosis, and virus release in cells cured of
respiratory syncytial virus persistent infection
Cristina Herranz a, José A. Melero b,c, Isidoro Martínez a,b,⁎
a Unidad de Interacción Virus-Célula, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
b Centro de Investigación Biomédica en Red, Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
c Unidad de Biología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain⁎ Corresponding author. Unidad de Interacción Vir
Microbiología, Instituto de Salud Carlos III, Majadah
Fax: +34 91 8223269.
E-mail address: imago@isciii.es (I. Martínez).
0042-6822/$ – see front matter © 2010 Elsevier Inc. Al
doi:10.1016/j.virol.2010.10.035a b s t r a c ta r t i c l e i n f oArticle history:
Received 30 July 2010
Returned to author for revision
25 August 2010
Accepted 24 October 2010
Available online 18 November 2010
Keywords:
Respiratory syncytial virus
Innate immune response
Apoptosis
Toll-like receptor
RIG-I
Chemokine
Interleukin
Virus persistenceIt has been reported that cell clones isolated at different passages from a culture of HEp-2 cells infected
persistently with human respiratory syncytial virus (HRSV) were cured of the virus. Further studies on one of
these clones (31C1) are reported here, showing that 31C1 cells can still be infected by HRSV but release low
amounts of virus to the culture supernatant, develop smaller and less numerous syncytia than the original
HEp-2 cells, and display only a weak innate immune response to the infection. Accordingly, uninfected 31C1
cells, but not clones derived from uninfected HEp-2 cells, express low levels of TLR3 and RIG-I. In addition,
31C1 cells are partly resistant to apoptosis. These results indicate that persistent infection of HEp-2 cells by
HRSV has selected cell variants, with changes affecting cell survival, virus growth and the innate immune
response that may be valuable for studies of virus–cell interaction.us-Célula, Centro Nacional de
onda, 28220 Madrid, Spain.
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Human respiratory syncytial virus (HRSV) (genus Pneumovirus,
family Paramyxoviridae) infects epithelial cells of the lower respira-
tory tract leading to serious illnesses, such as bronchiolitis and
pneumonia, in infants and in the elderly (Collins and Crowe, 2007).
Infection in early life increases the probability of subsequent long-
term episodes of wheezing and asthma (Perez-Yarza et al., 2007).
HRSV infection has also been associated with adult chronic obstruc-
tive pulmonary disease (COPD) (Sikkel et al., 2008). In all cases, an
inadequate immune/inﬂammatory response seems to contribute to
development of those pathologies (Collins and Graham, 2008;
Oshansky et al., 2009). Thus, along with virus replication, the
immune/inﬂammatory response is a major target for prophylactic
and/or therapeutic measures to control HRSV infection. The unfortu-
nate outcome of the vaccination trial conducted in the early 1960s, in
which children vaccinated with formalin-inactivated virus experi-
enced an enhanced disease upon natural subsequent HRSV infection,
has also boosted studies oriented to understand the relationshipbetween HRSV associated pathology and the immune response
(Kapikian et al., 1969; Prince et al., 2001).
The host response to HRSV infection begins in the epithelial cells of
the respiratory tract, where virus replication preferentially occurs
(Krishnan et al., 2004). These cells secrete chemokines and other
immune factors that attract lymphocytes and other cells to the site of
infection resulting in airway inﬂammation. Studies of the innate
immune response elicited in infected epithelial cells are, therefore,
instrumental to understand the pathology caused by HRSV.
Although HRSV normally results in lytic infections in humans,
model animals or susceptible cells, there is circumstantial evidence
that this virus can persist in the airways of laboratory animals (Hegele
et al., 1994; Schwarze et al., 2004; Streckert et al., 1996), or humans
(Sikkel et al., 2008; Wilkinson et al., 2006). Furthermore, susceptible
cells, such as HEp-2, which survive a lytic infection, become
persistently infected with HRSV, resulting in an attractive model for
studies of the innate immune response to the virus (Martinez et al.,
2009)
We have described previously the establishment of a culture of
HEp-2 cells persistently infectedwith HRSV. This culture turned out to
be an extremely complex example of virus–cell interaction in which
virus was produced at a relatively high constant level despite
heterogeneity among cells in viral antigen production, ranging from
high to undetectable levels. However, cell clones derived from early
passages (passage 4) of the persistently infected culture were
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detected (Martinez et al., 2009). These characteristics were also
observed in clones from later passages (passages 15 and 31).
We now report the characterization of a “cured” cell clone (31C1),
isolated after 31 passages of the persistently infected HEp-2 culture.
The aim behind this study was to assess if the persistent infectionmay
have selected cells with altered expression of genes relevant for virus
growth, cell survival and/or innate immune response. The selected
clone produced neither infectious virus, viral antigens or RNA, was
resistant to UV-induced apoptosis, and showed an impaired innate
immune response and decreased virus release when infected with
wild-type HRSV. Virus persistence seems to be a key factor for
selection of this cell phenotype since clones from the original,
uninfected cells did not show those changes.
Results
Cytopathic effect, virus replication and virus release in 31C1 cells
infected with HRSV
A culture of HEp-2 cells infected persistently with HRSV was
reported in which virus production wasmaintained constant for more
than twenty passages and a high heterogeneity was found at the cell
level regarding viral antigen expression (Martinez et al., 2009). Cell
clones derived from this culture were apparently cured of HRSV, since
they showed no morphological signs of infection, did not produce
detectable virus, were negative for HRSV antigens and no product was
ampliﬁed by RT-PCR with primers that readily ampliﬁed a conserved
region of the viral nucleoprotein gene in the persistently infected cells
(not shown). All clones were, however, susceptible to HRSV infection,
although virus production was lower than in the original HEp-2 cells
and syncytia were rarely observed. Since every cell clone obtained at
different passages of the persistent culture shared these character-
istics, one of them, obtained from the thirty ﬁrst passage (31C1), was
chosen for further studies, based on the hypothesis that the longer the
time the cells had been in the presence of the virus, the higher the
probability that changes were selected that might be relevant to
studies of HRSV–cell interaction. The 31C1 cells showed the above-
mentioned characteristics, including the development of smaller and
less numerous syncytia than HEp-2 cells following HRSV infection
(Fig. 1A). Although infected 31C1 cells died eventually, large syncytia
were not observed at any time; instead, rounding up of cells detached
from the plates and ﬂoating in the culture supernatants was the most
prominent effect observed at later times (48–72 h) after infection (not
shown). Furthermore, the amount of virus released to the supernatant
was approximately forty times lower in 31C1 cells by 20 h p.i., when
virus was growing exponentially (Fig. 1B). It has been reported
previously that a large proportion of the infectivity of HRSV remains
cell-associated in infected cultures (Bachi, 1988; Levine and Hamilton,
1969). Here, we conﬁrmed that in infected HEp-2 cells about ten times
more virus was recovered from the infected cells, after disaggregation
and brief sonication, than from the supernatant. In infected 31C1 cells,
however, the difference between the amount of virus recovered from
the infected cells and the supernatant was much higher, so that the
amount of cell-associated virus reached values only slightly lower
than those obtained from infected HEp-2 cultures (Fig. 1B). To test if
these observations could be extended to other viruses, similar
experiments were conducted using inﬂuenza and vesicular stomatitis
virus (VSV). No apparent differences in the cytophatic effect were
observed between HEp-2 and 31C1 cells after inﬂuenza or VSV virus
infection (not shown), but, in both cases, virus production was higher
in 31C1 cells, both in the supernatant and in the cell-associated
fraction (Fig. 1B).
The results fromHRSV infections suggest that virus replicationwas
apparently similar in both HEp-2 and 31C1 cells, but that virus release
was diminished in the later. To conﬁrm this point, HRSV replicationwasmonitored at early times p.i. by quantitative RT-PCR of a region of
the nucleoprotein gene. The kinetics of RNA accumulation in both
types of cells was indistinguishable within the ﬁrst 9 h of infection
(Fig. 1C, left). In addition, three independent infections were carried
out in order to monitor differences in the accumulation of viral RNA at
20 h p.i. By this time, when the amount of virus shed to the
supernatant was about forty times less in 31C1 cells than in HEp-2
cells, there were almost no differences in the amount of viral RNA,
estimated by quantitative RT-PCR (Fig. 1C, right).
The impairment in syncytia formation and virus release in 31C1
cells indicated that HRSV spreading was less efﬁcient in these cells
than in HEp-2. Flow cytometry of HEp-2 and 31C1 cells infected with
HRSV at high and lowMOI also supported this conclusion. Thus, when
a MOI of 5 pfu/cell was used, a single peak of ﬂuorescence was found
in the two types of cells. However, when a MOI ten times lower was
used for infection, two major peaks of ﬂuorescence were seen (Fig. 2).
One of them matched with the peak from MOI 5, and corresponded
presumably to cells infected by the inoculum. The other peak was less
intense and originated probably from a second round of infectionwith
virus released from the initially infected cells. The ﬂuorescence of the
ﬁrst peak was similar in HEp-2 and 31C1 cells, however the
ﬂuorescence of the second peak was less intense in 31C1 cells
(Fig. 2) than in HEp-2, reﬂecting reduced spreading of the infection in
the former cells.
31C1 cells are partially resistant to apoptosis
It has been previously reported that the persistently infected HEp-
2 cells, fromwhich 31C1 cells derived, are partly resistant to apoptosis
(Martinez et al., 2009). This might be either an inherent property of
the persistent infection itself, or an intrinsic property selected in the
cells that survive the infection. To clarify this point, 31C1 cells were
irradiated with UV light and fragmentation of DNA was analyzed by
agarose gel electrophoresis (Fig. 3A) and ELISA (Fig. 3B). Both
techniques gave similar results; 31C1 cells were more resistant than
HEp-2 cells to fragmentation of DNA induced by UV light. Quantitative
data from the ELISA test gave a difference of more than six times in the
amount of fragmented DNA between both cell types (Fig. 3B).
The innate immune response is impaired in 31C1 cells
HRSV infection elicits a strong innate immune response in many
cell types, including HEp-2 (Martinez et al., 2009; Zhang et al., 2001).
Since 31C1 cells, or rather the precursors from which they originate,
had been in contact with HRSV for many passages, we reasoned that
this passage history might have selected for cells with a modiﬁed
innate immune response to the virus. Thus, the innate immune
responses of 31C1 and HEp2-cells to HRSV infectionwere compared at
three different levels: expression of pattern recognition receptors
(PRRs), activation of transcription factors, and secretion of cytokines
(Fig. 4).
Since PRRs are essential factors in detecting viral infection and
triggering of the antiviral innate immune response, the expression of
TLR4, TLR3 and RIG-1, three PRRs involved in the innate response
against HRSV in epithelial cells (Klein Klouwenberg et al., 2009), were
quantiﬁed by real-time RT-PCR in uninfected HEp-2 and 31C1 cells.
Whereas the amount of mRNA corresponding to TLR4 was almost
equal in both cell types, the amount of TLR3 and RIG-I was
approximately twenty-ﬁve and eleven times lower in 31C1 than in
HEp-2 cells, respectively (Fig. 4A). These results suggested that the
innate immune response of 31C1 cells to HRSV infection, mediated by
those two PRRs, could be substantially weaker in 31C1 than in HEp-2
cells. If this were indeed the case, it would be likely to affect the
expression and activation of key transcription factors involved in that
response. Activation of NF-κB, as seen by degradation of IKBα, and
induction of c-Jun were evident after infection of HEp-2 cells with
Fig. 1. (A) Cytopathic effect of HEp-2 and 31C1 cell cultures infected with HRSV (Long strain). Cells were either uninfected (top panels) or infected with HRSV at a MOI of 1 pfu/cell
and photographed at 24 h p.i. Note the presence of syncytia in infected HEp-2 cells (arrows), which were absent from the infected 31C1 culture. (B) Virus growth after infection of
HEp-2 and 31C1 cells with HRSV at a MOI of 3 pfu/cell. Virus titer was determined by plaque assay with a mixture of anti-G and anti-F antibodies in the clariﬁed (5000×g/10 min)
supernatant of infected cells. Virus yields in the culture supernatant and associated with cells were compared at 20 h p.i. For cell-associated virus, cells were washed with DMEM2,
scrapped off in fresh DMEM2, disaggregated by thoroughly pippeting and brief sonication in an ultrasonic bath, and virus titrated in the clariﬁed supernatant. Similar experiments
were carried out for inﬂuenza and VSV viruses, except that inﬂuenza infections were done in the absence of FCS and VSV titration was done at 6 h p.i. Mean and standard deviation of
three experiments are shown. (C) Left panel: Accumulation of HRSV nucleoprotein RNA (N) in infected HEp-2 and 31C1 cells (MOI of 3 pfu/cell) estimated by quantitative RT-PCR.
Right panel: Relative accumulation of N RNA in 31C1 cells compared with HEp-2 cells at 20 h p.i. using β-actin (ACTB) as endogenous control (the mean and standard deviation of
three experiments are shown). Threshold cycle (CT) is the PCR cycle number at which the ﬂuorescence signal meets the threshold in the ampliﬁcation plot.
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(Fig. 4B). As already reported (Casola et al., 2000; Jamaluddin et al.,
1998), induction of c-Jun represents an early event after HRSV
infection of HEp-2 cells, whereas degradation of IKBα occurs at later
times (Fig. 4B).
In agreement with the low expression of PRRs and the low
activation of transcription factors involved in the innate immune
response, 31C1 cells secreted lower amounts of several cytokines into
the culture supernatant after virus infection than HEp-2 cells (Fig. 4C).
This was more evident for CXCL8 (IL-8), IL-6 and CCL5 (RANTES) that
were expressed four, thirty four and one hundred and twenty two
times less, respectively, in 31C1 than in HEp-2 cells after HRSVinfection (20 h p.i.). In all cases, basal expression, corresponding to
non-infected cells, was also lower in 31C1 than in HEp-2 cells
(Fig. 4C).
The induction of IFN-βwas also tested in infected HEp-2 and 31C1
cells, but no signiﬁcant induction of this cytokine was observed in
either cell type (not shown). This might be related to the ability of
HRSV to block the activation of IFN-β transcription (Ling et al., 2009;
Spann et al., 2005; Swedan et al., 2009). It is generally accepted that
IFN-β induction is triggered by recognition of viral RNAs by PRRs. RIG-
I and TLR3 also recognize artiﬁcial RNAs, such poly(I:C), leading to
type I IFN induction (Baum and Garcia-Sastre). Thus, we decided to
test the induction of IFN-β after poly(I:C) stimulation of HEp-2 and
Fig. 2. Flow cytometry of HEp-2 and 31C1 cells. Cells were either infected atMOI of 5 or 0.5 pfu/cell, or left uninfected (mock). Twenty hours later, the cells were resuspended, stained
with a mixture of anti-F (47F) and anti-G (021/1G) monoclonal antibodies and the ﬂuorescence was measured by ﬂow cytometry. Dotted lines correspond to 31C1 cells and
continuous lines to HEp-2 cells.
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observed only in HEp-2 cells following poly(I:C) transfection with
DEAE-Dextran, but not in 31C1 cells.
From the above experiments, it became apparent that the initial
innate immune response triggered by virus infection andmediated by
PRRs was impaired in 31C1 cells. This response usually leads to the
synthesis of interferon that, in turn, induces the production of many
antiviral products (Randall and Goodbourn, 2008). To test whether or
not 31C1 cells were also deﬁcient in the induction of this second wave
of the cellular innate immune response, expression of RIG-I, anFig. 3. DNA fragmentation in cells irradiated with UV light. (A) Cells were irradiated
with UV light for 5 min, incubated for 3 h at 37 °C, and 3 μg of extracted DNA were
loaded into a 2% agarose gel. (B) Alternatively, DNA fragmentation was quantiﬁed by
ELISA in samples of three independent experiments (see Materials and methods).interferon stimulated gene that is instrumental in triggering the
innate immune response to HRSV, was analyzed. HRSV infection
enhanced expression of this gene about seven times in HEp-2 cells,
but not in 31C1 cells (Fig. 5, HRSV). Furthermore, treatment of HEp-2
cells with IFN-β also enhanced the expression of RIG-I about eleven
times, but in contrast to HRSV infection, this treatment also enhanced
the expression of RIG-I in 31C1 cells by more than ﬁfty times (Fig. 5,
IFN-β). Therefore, 31C1 cells were capable of responding to
exogenous IFN-β. Note that the levels of mRNAs represented in
Fig. 5 after IFN-β stimulation are relative to the corresponding non-
treated cells, HEp-2 or 31C1.When a direct comparison between HEp-
2 and 31C1 IFN-β stimulated cells was carried out, the relative levels
of RIG-I were about three times higher in HEp-2 cells than in 31C1
cells (not shown). This is because of the very low expression of basal
RIG-I in 31C1 cells.
Finally, an important question was whether additional clones with
the same properties of 31C1 cells could be obtained from the
persistently infected culture from which 31C1 derived, as well as
from uninfected HEp-2 cells. To consider this question, ﬁve cell clones
were isolated from uninfected HEp-2 cells by limiting dilution, and
basal expression of TLR3 and RIG-I mRNA was examined along with
ﬁve clones derived from passage four and ﬁfteen of the HRSV
persistently infected cells (Martinez et al., 2009). Basal expression of
TLR3 and RIG-I in the ﬁve clones derived from uninfected cells varied
between approximately half and twice the value found in uncloned
HEp-2 cells, but never reached the extremely low values found in the
clones derived from the persistently infected culture, especially after
the ﬁfteenth passage (Fig. 6).
Discussion
In a previous study, we established a culture of HEp-2 cells
persistently infected with HRSV, from the few cells that survived a
lytic infection. Analysis of the persistently infected culture showed
great heterogeneity between cells at the level of viral antigen
expression, ranging from negative to high positivity as measured by
ﬂow cytometry (Martinez et al., 2009). To simplify the study, cells
from the persistent culture were cloned at different passages (fourth,
ﬁfteenth and thirty-ﬁrst). In all cases, the cell clones were “cured” of
HRSV, however they were still susceptible to virus infection (Martinez
et al., 2009). In the present study we have examined more in depth
the characteristics of one of these cell clones, obtained after thirty-one
weekly passages of the persistently infected culture. This clone (31C1)
did not produce either infectious virus or viral antigens, and no viral
RNA was detected. HRSV infected and replicated in 31C1 cells as
Fig. 4. Reduced innate immune response in 31C1 cells. (A) Relative expression of TLR4, RIG-I and TLR3 mRNA in 31C1 compared with HEp-2 cells. Quantitative RT-PCR was
performed for the indicated genes in uninfected 31C1 and HEp-2 cells and compared using the gene of ACTB (β-actin) as endogenous control. Data represent the mean and standard
deviation from three experiments. (B) Degradation of IKBα and expression of c-Jun in 31C1 and HEp-2 infected cells (MOI of 3 pfu/cell). Ten micrograms of total proteins from the
corresponding cell extracts were fractionated by SDS-PAGE and visualized by Western blotting with speciﬁc antibodies. An antibody against β-actin (ACTB) was included as an
internal control. The amount of viral nucleoprotein (N) was assessed with a speciﬁc monoclonal antibody (021/2N) as a control of the infection. (C) Accumulation of cytokines in the
supernatant of 31C1 and HEp-2 cells after 20 h of infection with HRSV (MOI of 3 pfu/cell), as determined by solid phase sandwich ELISA. Mean and standard deviations of three
independent experiments are shown. (D) Induction of IFN-β in poly(I:C) treated HEp-2 and 31C1 cells. HEp-2 and 31C1 cells were incubated for 30 h in the presence of 10 μg/ml poly
(I:C) alone, 10 μg/ml DEAE-Dextran alone, a mixture of both or left untreated (control). IFN-β was measured in the supernatant by ELISA. Mean and standard deviations of three
independent experiments are shown.
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virus release were impaired. In addition, 31C1 cells were resistant to
apoptosis, and responded to HRSV infection with a weak innate
immune response.
Analyses of cell clones derived from cultures persistently infected
with other viruses have contributed to understanding viral and/or
cellular processes relevant for virus infection, such as viral attachment
and entry (Borzakian et al., 1992; Dermody et al., 1993; Kaplan et al.,
1989; Mrukowicz et al., 1998; Zhong et al., 2006). In 31C1 cells, HRSV
attachment, entry, and replication were apparently unaffected, but
release of virus to the culture supernatant was diminished when
compared with the parental HEp-2 cells, a characteristic apparently
speciﬁc for HRSV infection, since it was not observed with other
viruses such as inﬂuenza or VSV. This limitation in HRSV release,together with a clear inhibition of syncytia formation, led to a
decreased spreading of HRSV in 31C1 infected cells. This may have
favored cell survival in the original persistently infected culture,
although additional viral and/or cellular characteristics might have
also played a role, since HRSV infection of 31C1 cultures eventually led
to cell death. The reason for the low release of virus in 31C1 cells is
unknown, although possible mechanisms are currently under inves-
tigation. For example, cholesterol biosynthesis is required for
assembly and budding of several viruses, including HRSV (Robinzon
et al., 2009; Yeo et al., 2009), therefore differences in cholesterol
biosynthesis may exist between HEp-2 and 31C1 cells. Proteins of the
host machinery involved in HRSV budding, such as those of the Rab11
family, are also necessary for virus release (Utley et al., 2008).
Differences in the composition and/or amount of plasma membrane
Fig. 5. RIG-I expression in cells infected with HRSV (MOI of 3 pfu/cell, 20 h p.i.) or
treated with interferon-β (500 U/ml, 3 h after the treatment). The amount of RIG-I RNA
was determined by quantitative RT-PCR and compared with uninfected (HRSV) or non-
treated (IFN-β) cells using ACTB as an endogenous control. Data represent the mean
and standard deviation from three experiments. Fold-change equal to 1 (no changes in
mRNA expression between uninfected and infected cells) is represented by a dashed
line.
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2000; Krusat and Streckert, 1997; Martinez and Melero, 2000), may
contribute to retaining the virus at the cell surface, given that HRSV
lacks a receptor-destroying activity to liberate progeny virions from
the plasma membrane. Finally, differences in the phosphorylation of
HRSV phosphoprotein (P) in HEp-2 and 31C1 cells may account for
differences in virus release, since it has been described that mutations
of the serines at several phosphorylation sites of the HRSV P
substantially increase the amount of cell-associated virus (Lu et al.,
2002).
It has been reported that HRSV induces cell apoptosis at late stages
of infection (Monick et al., 2005; O'Donnell et al., 1999). Therefore, it
is relevant that 31C1 cells are partly resistant to apoptosis. This
characteristic should facilitate cell survival but, at the same time,
would support virus production for a longer time in the infected cell.
Thus, an equilibrium may be reached that beneﬁts both the virus and
the cell while establishment of the persistent infection. In other virus–
cell systems it has been found that inhibition of apoptosis facilitates,
among others, persistent infections of HIV-1 and hepatitis C virus
(Antoni et al., 1995; Mankouri et al., 2009), and it has been described
that cells cured of a persistent poliovirus infection showed reduced
apoptosis (Labadie et al., 2007).
It was observed that the innate immune response of 31C1 cells to
infection with HRSV was defective. However, it is important to noteFig. 6. Expression of RIG-I and TLR3 in uncloned HEp-2 cells and clones derived from them (
was used to determine the amount of mRNA in each culture. Relative expression to uncloned
from the persistently infected HEp-2 culture were obtained after passage 4 (4C1, 4C2, 4C3that 31C1 cells do not show a generalized impairment of the innate
immune response, since they responded to IFN-β when added
exogenously. Instead, a very early and speciﬁc step involved in the
detection of virus infection seems to be affected. The innate immune
response in infected cells is initiated by pattern recognition receptors
such as toll-like receptors (TLRs), retinoic acid-inducible protein I
(RIG-I) and melanoma differentiation-associated protein-5 (Mda5)
(Kawai and Akira, 2008; Randall and Goodbourn, 2008). Speciﬁcally,
TL3, and RIG-I have a central role in the recognition of HRSV RNA in
infected epithelial cells (Liu et al., 2007; Rudd et al., 2005). This
recognition activates the transcription factors IRF3, NF-κB, and AP-1,
leading to the induction of cytokine production (Kawai and Akira,
2008). Thus, it is likely that the very low expression levels of TLR3 and
RIG-I in uninfected 31C1 cells were responsible for the weak
activation of NF-κB and c-JUN (AP-1), and subsequent low production
of CCL5 (RANTES), CXCL8 (IL-8) and IL-6, in 31C1 infected cells, a
hypothesis supported by the lack of 31C1 cells response to poly(I:C)
stimulation. A marked suppression of IL-8, RANTES, TNF-α and IL-6
production and NF-κB activation after lipopolysaccharide stimulation
of monocytic cells persistently infected with measles virus has been
reported recently, although no signiﬁcant differences in the level of
expression of TLRs were found (Indoh et al., 2007). The very low
expression of PRRs in 31C1 cells was not observed in clones derived
from uninfected HEp-2 cells, but it was observed in all clones selected
at different passages of the persistently infected culture from which
31C1 cells were obtained, strongly indicating that this characteristic
was acquired because of the selective pressure of HRSV infection. Cell
variants with different modiﬁcations have also been selected from
other virus–cell systems (Ahmed et al., 1981; Chen and Baric, 1996; de
la Torre et al., 1989, 1988; Dermody et al., 1993; Martin Hernandez et
al., 1994; Mrukowicz et al., 1998; Ron and Tal, 1985; Zhong et al.,
2006).
The possibility that airway epithelial cell variants similar to 31C1
cells may also arise in vivo should be considered. The rapid renewal of
the airway epithelium, especially after injury (Crystal et al., 2008;
Heguy et al., 2007), would provide the cellular substrate on which
HRSV infection may exert a selective pressure. Selection of cell
variants that support HRSV replication for long time (i.e. resistant to
apoptosis and/or with an impaired innate immune response to the
virus) may occur in an environment of continuous cell renewal and
replicating virus. This scenario may be similar to that described for
some chronic respiratory pathologies, such as chronic obstructive
pulmonary disease (COPD), in which HRSV RNA has been detected
during extended periods of time in the stable phase of the disease
(Sikkel et al., 2008; Wilkinson et al., 2006). Thus, 31C1 cells may be a
useful “in vitro” model system for studies on the interaction of HRSV
and respiratory epithelial cells “in vivo”, although some caveats must
be taken into account because of the additional complexity of the “in
vivo” situation.grey bars) and from the persistently infected culture (white bars). Quantitative RT-PCR
HEp-2 was calculated in triplicate using ACTB as endogenous control. The clones derived
and 4C4), passage 15 (15C1) or passage 31 (31C1).
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Cells and viruses
The human HEp-2 and canine MDCK epithelial cell lines, and the
baby hamster kidney (BHK-21) cells were grown in Dulbecco's
modiﬁed Eagle's medium (Lonza) supplemented with 10% fetal calf
serum (FCS) (Linus), 4 mM glutamine (Lonza), 100 U/ml penicillin
(Lonza) and 100 U/ml streptomycin (Lonza) (DMEM10) at 37 °C in 5%
CO2. The Long strain of HRSV was propagated in HEp-2 cells in DMEM
with 2% FCS, glutamine and antibiotics (DMEM2). Viruses were
puriﬁed from clariﬁed culture supernatants by polyethylene glycol
precipitation and centrifugation in a 30–45–60% discontinuous
sucrose gradient, and titrated by plaque assay in HEp-2 cells as
previously described (Martinez et al., 2007). HEp-2 cells persistently
infectedwith the Long strain of HRSVwere obtained by culture of cells
that survived a lytic virus infection in DMEM10 at 37 °C in 5% CO2 and
passaged weekly at 1/3 dilution (Martinez et al., 2009). Persistently
infected cells were cloned at passage thirty-one by two rounds of
limiting dilution to obtain 31C1 cells: In brief, cells were trypsinized
and serial two-fold dilutions were plated in 96-well microplates.
Wells were monitored daily for cell growth and those at the highest
dilution that showed individual clones were trypsinized again and
replated as before. After this second round of cloning, cells in the
selected wells (those from the highest dilution showing a single
clone) were trypsinized and expanded. The A/Victoria/3/75 strain of
inﬂuenza virus was propagated in MDCK cells in the absence of FCS
and the presence of 25 μg/ml of trypsin. Vesicular stomatitis virus
(Indiana serotype) was grown in BHK-21 cells. Virus titers were
determined by plaque assay in MDCK (inﬂuenza) or BHK-21 cells
(VSV) layered with 0.7% low-melting point agarose (Conda).
Antibodies
Antibodies againstG (021/1G, 021/2G), F (47F),N (021/N,79N) andP
(67P) proteins of HRSV have been described previously (Garcia-Barreno
et al., 1989; Martinez et al., 1997). Mouse monoclonal against beta actin
(ab8224), rabbit monoclonals against c-JUN (ab32137) and IKB alpha
(ab32518), and goat polyclonal to rabbit IgG, horseradish peroxidase
linked whole antibody, were obtained from Abcam (UK). Anti-mouse
IgG, horseradish peroxidase linked whole antibody (from sheep) was
purchased from GE Healthcare. Goat anti-mouse IgM+IgG+IgA
(H+L) R-phycoerythrin conjugate was obtained from SouthernBiotech.
Quantitative RT-PCR and Western blots
HEp-2 and 31C1 cells weremock-infected or infectedwith puriﬁed
virus (Long strain) in DMEM2. After 90 min of adsorption, fresh
medium was added and cells were incubated at 37 °C. Total RNA was
extracted with TRIZOL reagent (Invitrogen) and further puriﬁed with
the RNeasy kit (Qiagen) at the post-infection (p.i.) time indicated in
the ﬁgure legends. RNA was reverse-transcribed with the High-
Capacity cDNA Archive Kit (Applied Biosystems) and ampliﬁed using
TaqMan quantitative gene expression assays (Applied Biosystems).
PCR primers and TaqMan MGB probes (FAM dye-labeled) for the
following genes were products from Assays-on-demand (Applied
Biosystems): ACTB (Hs99999903_m1), TLR4 (Hs00152939_m1), TLR3
(Hs01551078_m1) and DDX58 (RIG-I) (Hs00204833_m1). PCRs were
performed in triplicate following the manufacturer´s protocols on a
StepOne sequence detection system (Applied Biosystems). ACTB
(β-actin) cDNA was used as an endogenous control and the
comparative CT (ΔΔCT) method was used for relative quantiﬁcations
(Applied Biosystems User Bulletin no.2). A Custom TaqMan Gene
Expression Assay (Applied Biosystems) was used for ampliﬁcation
and quantiﬁcation of the nucleoprotein RNA of HRSV (forwardprimer: 5´CATGATTCTCCTGATTGTGGGATGA 3´, reverse primer: 5´
TCACGGCTGTAAGACCAGATCTAT 3´, probe: 5´CCCCTGCTGCCAATTT3´).
In some experiments, protein cell extracts were prepared from
cultures infected under the same conditions as those used for RNA
extraction. Proteins were separated by SDS-PAGE and analyzed by
Western blotting with the antibodies indicated in each ﬁgure.
Flow cytometry
Cells were detached with PBS-10 mM EDTA, incubated for 20 min at
4 °C with a mixture of 021/2G and 47F antibodies, washed with PBS-2%
FCS, incubated for another 20 min with the secondary antibody (goat
anti-mouse IgM+IgG+IgA (H+L) R-phycoerythrin conjugate),
washed and ﬁxed with 1% paraformaldehyde. Sample ﬂuorescence was
measured on a FACS-Canto ﬂow cytometer (BD Biosciences, San Jose, CA,
USA)andanalyzedusingFlowJo7.5.2. software (TreeStar, SanCarlos, CA).
DNA fragmentation assay
Cells were irradiated with UV light for 5 min in PBS. After this
period, PBS was aspirated, fresh medium was added, and the cells
were incubated for 3 h at 37 °C. Following the incubation period, cells
were detached with PBS-1 mM EDTA and DNAwas extracted with the
Easy-DNA kit (Invitrogen). Three micrograms of DNA were loaded
onto a 2% agarose gel and visualized with GelRed Nucleic Acid Gel
Stain (Biotium). Alternatively, DNA fragmentation was determined by
Cell Death Detection ELISA (Roche), a photometric enzyme immuno-
assay for detection of cytoplasmic histone-associated DNA fragments
(mono- and oligonucleosomes) after induced cell death.
ELISA assays for cytokines
Semiconﬂuent 90 mm dishes of HEp-2 and 31C1 cells were mock-
infected or infected with the Long strain of HRSV in DMEM2 at a MOI
of 3 pfu/cell. Twenty hours later, the amount of the chemokines CCL2/
MCP-1, CCL3/MIP-1α, CCL5/RANTES and the interleukins IL-6 and
IL-8 was determined in the clariﬁed supernatant by solid phase
sandwich ELISA kits, following manufacturer protocols (Invitrogen,
KHC1011, KAC2201, KHC1031, KAC1261 and KHC0081).
Poly(I:C) treatment
Semiconﬂuent HEp-2 and 31C1 cells growing in 6-wells plates were
treated with either 10 μg/ml of poly(I:C) (Sigma-Aldrich, P9582),
10 μg/ml of DEAE-Dextran (Sigma-Aldrich, D9885) or 10 μg/ml of poly
(I:C)plus10 μg/mlofDEAE-Dextran for 30 h.After this time, theamount
of IFN-β was measured in the clariﬁed culture supernatant by ELISA
(Invitrogen, KAC1201).
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